4 hybrid o bell, Construction swyddi yn Cheshire
Hyderus o ran Anabledd
Gweithio o bell
Lleoliad
- UK
- North West England
- Cheshire (4)
- Chester (1)
- Ellesmere Port (1)
- Macclesfield (1)
- Warrington (1)
Dyddiad hysbysebu
Categori
- Swyddi peirianneg (2)
- Swyddi TG (1)
- Swyddi cynnal a chadw (1)
Math o gytundeb
- Parhaol (4)
Oriau
- Llawn amser (4)
Mewngofnodwch nawr i greu rhybudd e-bost a derbyn y swyddi diweddaraf ar gyfer y chwiliad hon yn syth i'ch e-bost
MewngofnodiMulti Utilities Designer
- 24 May 2024
- Hays Specialist Recruitment - Warrington, Cheshire, wa11sl
- £40,000.0 to £55,000.0 per year
- £40000 - £55000 overtime & package
- Hybrid o bell
- Parhaol
- Llawn amser
Your new company You will be joining an established ICP who operate nationally, due to expansion, looking for a Multi Utilities Designer to join the team working hybrid. They are one of the only ICPs capable of working with voltages up to 132kV, installing ...
Senior Surveyor
- 30 May 2024
- ForHousing - Ellesmere Port, Cheshire
- £46,104 to £46,104 per year
- plus benefits
- Hybrid o bell
- Parhaol
- Llawn amser
Everything we do aims to positively impact the lives of our social housing tenants and deliver on what matters to them and their communities. We provide safe, well-maintained, sustainable homes and deliver customer-focused services. ForHousing is a place where...
Senior Structural (BIM) Technician
- 04 June 2024
- Hays Specialist Recruitment - Chester, Cheshire, CH1 1AB
- £40,000.0 to £60,000.0 per year
- £45,000 - £55,000
- Hybrid o bell
- Parhaol
- Llawn amser
Your new company Your new company is a Top 10 ranked global engineering consultancy with 1650 employees across the UK. With office locations in most major UK cities, your new company have a Building Structures Team for the North spread across Chester, ...
IT Quality & Compliance Director
- 12 June 2024
- Astrazeneca - Macclesfield, Cheshire, SK10 2NA
- Hybrid o bell
- Parhaol
- Llawn amser
AstraZeneca is a global, innovation-driven BioPharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines for some of the world's most serious diseases. But we're more than one of the world's leading ...
- 1